12:00 AM
 | 
Jul 20, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Remeron/Reflex mirtazapine regulatory update

Schering-Plough said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Remeron/Reflex mirtazapine to treat major depressive disorder in adults. Schering-Plough and Meiji Seika Kaisha Ltd....

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >